{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:25:14Z","timestamp":1767918314414,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Monbu Kagakusho","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K10906"],"award-info":[{"award-number":["JP23K10906"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jphs.2024.12.003","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T17:24:24Z","timestamp":1734024264000},"page":"65-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Thrombin-induced kynurenine 3-monooxygenase causes variations in the kynurenine pathway, leading to neurological deficits in a murine intracerebral hemorrhage model"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0940-8523","authenticated-orcid":false,"given":"Masatoshi","family":"Ohnishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Banshoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoi","family":"Machida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukino","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuui","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumpei","family":"Tasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mana","family":"Furutaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Shigemasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2024.12.003_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","article-title":"Endogenous kynurenines as targets for drug discovery and development","volume":"1","author":"Stone","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jphs.2024.12.003_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2024.12.003_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid","volume":"247","author":"Perkins","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/j.jphs.2024.12.003_bib4","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","article-title":"3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum","volume":"11","author":"Guidetti","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jphs.2024.12.003_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/bj3260351","article-title":"Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types","volume":"326","author":"Heyes","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.jphs.2024.12.003_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.drudis.2015.11.001","article-title":"Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors","volume":"21","author":"Smith","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jphs.2024.12.003_bib7","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1471-4159.2010.06675.x","article-title":"Dysfunctional kynurenine pathway metabolism in the R6\/2 mouse model of Huntington's disease","volume":"113","author":"Sathyasaikumar","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.jphs.2024.12.003_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2006.02.011","article-title":"Elevated brain 3-hydroxykynurenine and quinolinate in Huntington disease mice","volume":"23","author":"Guidetti","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jphs.2024.12.003_bib9","first-page":"2442","article-title":"In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease","volume":"30","author":"Heng","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.jphs.2024.12.003_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnins.2014.00012","article-title":"Kynurenines in CNS disease: regulation by inflammatory cytokines","volume":"8","author":"Campbell","year":"2014","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jphs.2024.12.003_bib11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/jphp.13235","article-title":"Gadolinium causes M1 and M2 microglial apoptosis after intracerebral haemorrhage and exerts acute neuroprotective effects","volume":"72","author":"Ohnishi","year":"2020","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"10.1016\/j.jphs.2024.12.003_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273037","article-title":"Indoleamine 2, 3-dioxygenase is responsible for low stress tolerance after intracerebral hemorrhage","volume":"18","author":"Ohnishi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2024.12.003_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0022-510X(95)00164-W","article-title":"Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children","volume":"113","author":"Heyes","year":"1995","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jphs.2024.12.003_bib14","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/j.jphs.2024.12.003_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2018.10.029","article-title":"Shogaol but not gingerol has a neuroprotective effect on hemorrhagic brain injury: contribution of the \u03b1, \u03b2-unsaturated carbonyl to heme oxygenase-1 expression","volume":"842","author":"Ohnishi","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2024.12.003_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2008.02.052","article-title":"Effects of kynurenine 3-hydroxylase inhibitor Ro61-8048 after intrastriatal injections on the severity of dystonia in the dt sz mutant","volume":"586","author":"Hamann","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2024.12.003_bib17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1124\/jpet.111.182519","article-title":"Therapeutic effect of nicotine in a mouse model of intracerebral hemorrhage","volume":"338","author":"Hijioka","year":"2011","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.jphs.2024.12.003_bib18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.neuropharm.2011.06.026","article-title":"HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats","volume":"61","author":"Ohnishi","year":"2011","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.jphs.2024.12.003_bib19","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1161\/01.STR.0000032302.91894.0F","article-title":"Behavioral tests after intracerebral hemorrhage in the rat","volume":"33","author":"Hua","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jphs.2024.12.003_bib20","article-title":"Modified behavioral tests to detect white matter injury-induced motor deficits after intracerebral hemorrhage in mice","volume":"9","author":"Chen","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphs.2024.12.003_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3171\/jns.1996.84.1.0091","article-title":"Edema from intracerebral hemorrhage: the role of thrombin","volume":"84","author":"Lee","year":"1996","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jphs.2024.12.003_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0038-1661594","article-title":"A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes","volume":"56","author":"Hemker","year":"1986","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.jphs.2024.12.003_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbi.2022.07.011","article-title":"C-reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder","volume":"105","author":"Zheng","year":"2022","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jphs.2024.12.003_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2006.10.042","article-title":"Role of GABAergic antagonism in the neuroprotective effects of bilobalide","volume":"1128","author":"Kiewert","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.jphs.2024.12.003_bib25","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.neuroscience.2006.09.049","article-title":"Thrombin induces striatal neurotoxicity depending on mitogen-activated protein kinase pathways in vivo","volume":"144","author":"Fujimoto","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.jphs.2024.12.003_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nbd.2005.10.008","article-title":"Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organotypic slice cultures","volume":"22","author":"Fujimoto","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jphs.2024.12.003_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11481-023-10065-y","article-title":"Long-term stimulation of \u03b17 nicotinic acetylcholine receptor rescues hemorrhagic neuron loss via apoptosis of M1 microglia","volume":"18","author":"Ohnishi","year":"2023","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.jphs.2024.12.003_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/srep29246","article-title":"Protease activated receptor 1 (PAR1) enhances Src-mediated tyrosine phosphorylation of NMDA receptor in intracerebral hemorrhage (ICH)","volume":"6","author":"Duan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphs.2024.12.003_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-211-09469-3_9","article-title":"Intracerebral hemorrhage injury mechanism: glutamate neurotoxicity, thrombin, and Src","volume":"105","author":"Sharp","year":"2008","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.jphs.2024.12.003_bib30","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1046\/j.1471-4159.2001.00517.x","article-title":"The neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site","volume":"78","author":"Herin","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.jphs.2024.12.003_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-020-00421-4","article-title":"Increase serum QUIN\/KYNA is a reliable biomarker of post-stroke cognitive decline","volume":"16","author":"Cogo","year":"2021","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.jphs.2024.12.003_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","article-title":"Expression of the kynurenine pathway enzymes in human microglia and macrophages","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jphs.2024.12.003_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/schbul\/sbq002","article-title":"Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in schizophrenia","volume":"36","author":"Wonodi","year":"2010","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jphs.2024.12.003_bib34","first-page":"309","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jphs.2024.12.003_bib35","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.jphs.2024.12.003_bib36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00494-P","article-title":"Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease","volume":"65","author":"Huang","year":"1995","journal-title":"Neurosci"},{"key":"10.1016\/j.jphs.2024.12.003_bib37","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington's disease","volume":"11","author":"Beal","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.jphs.2024.12.003_bib38","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1523\/JNEUROSCI.10-09-02965.1990","article-title":"Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors","volume":"10","author":"Swartz","year":"1990","journal-title":"J Neurosci"},{"key":"10.1016\/j.jphs.2024.12.003_bib39","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/npp.2013.71","article-title":"NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861324000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861324000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T22:03:24Z","timestamp":1737324204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861324000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1347861324000793"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2024.12.003","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombin-induced kynurenine 3-monooxygenase causes variations in the kynurenine pathway, leading to neurological deficits in a murine intracerebral hemorrhage model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2024.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}